ANVISA

Related by string. Anvisa * * *

Related by context. Frequent words. (Click for all words.) 65 Swissmedic 60 Clinical Trial Application 59 CE Marked 59 Orphan Drug status 59 MHLW 58 Ceftobiprole 57 Notified Body 56 Marketing Authorization 56 orphan designation 56 Toctino ® 56 Toctino R 56 Nimotuzumab 56 USFDA approval 55 FDA Accepts 55 Medicinal Products EMEA 55 Sucanon ® 55 Orphan Drug Status 55 USFDA 55 DCGI 55 Generex Oral lyn 55 Marketing Authorization Application 55 CE Marking 55 Clevudine 54 DC Bead 54 Plenaxis R 54 Phase III Clinical Trial 54 Therapeutic Products 53 Orphan Drug designation 53 Rotarix R 53 Tenofovir 53 Mutual Recognition Procedure 53 Angiox 53 GMP certification 53 Generex Oral lyn TM 53 Analgesics 52 Venus Remedies 52 Telavancin 52 Pivotal Phase III 52 CGMP 52 ATryn ® 52 ISO Certification 52 THELIN 52 orphan medicinal product 52 Pharmacopeia USP 52 NOXAFIL 52 Cladribine 51 Abstral 51 Cimzia ® 51 BEMA Fentanyl 51 Orphan Medicinal Product 51 Ampligen 51 Avastin bevacizumab 51 IBAMA 51 FIRAZYR 51 taliglucerase alfa 50 Aptivus 50 Vitaros 50 ELAPRASE 50 IPLEX 50 human antithrombin 50 de Valores 50 Generic Version 50 Maraviroc 50 Microcyn Technology 50 GEM #S 50 SEMARNAT 50 Toctino 50 Aridol 50 Drugs Controller 50 Crofelemer 50 Fast Track Designation 50 oral insulin Generex 50 SFDA 50 Avelox 50 Extended Release 50 Icatibant 50 Mitigation Strategy 49 VALSTAR 49 India DCGI 49 Drug Application 49 European Medicines Evaluation 49 Factive 49 Pirfenidone 49 Cerepro 49 Biologics License Application 49 ceftobiprole 49 Receives CE 49 Marketing Authorization Application MAA 49 PharmaMar 49 Positive Opinion 49 Drug Administration USFDA 49 Pulmonary Arterial Hypertension 49 Patent Covering 49 CHMP opinion 49 Committee GEAC 49 Tecnologia 49 Act PDUFA date 49 SFDA approval 49 Drug Controller 49 Alvesco 49 Research CDER

Back to home page